Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Amitriptyline hydrochloride by AlgoTherapeutix for Chemotherapy Induced Peripheral Neuropathy: Likelihood of Approval
Amitriptyline hydrochloride is under clinical development by AlgoTherapeutix and currently in Phase II for Chemotherapy Induced Peripheral Neuropathy. According to...
Amitriptyline hydrochloride by AlgoTherapeutix for Erythromelalgia: Likelihood of Approval
Amitriptyline hydrochloride is under clinical development by AlgoTherapeutix and currently in Phase II for Erythromelalgia. According to GlobalData, Phase II...
Amitriptyline hydrochloride by AlgoTherapeutix for Diabetic Peripheral Neuropathy: Likelihood of Approval
Amitriptyline hydrochloride is under clinical development by AlgoTherapeutix and currently in Phase I for Diabetic Peripheral Neuropathy. According to GlobalData,...
Amitriptyline hydrochloride by AlgoTherapeutix for Erythromelalgia: Likelihood of Approval
Amitriptyline hydrochloride is under clinical development by AlgoTherapeutix and currently in Phase II for Erythromelalgia. According to GlobalData, Phase II...